Abstract:Introduction: Regulatory T cells (Treg) have been shown to prevent allograft rejection and plays an important role in promote donorspecific antigenic tolerance in solid organ transplantation. In this study, we analyzed the ratio of CD4+CD25+Foxp3+/Th17 T cell in the peripheral blood of kidney recipients with living-related donor in different immunosuppressive therapy, and analyzed the relationship between the ratio of CD4+CD25+Foxp3+/Th17 T cell and patients who have long-term survival. Methods: The study was approved by the local ethical committee. Twelve renal transplant recipients with living-related donor received combined donor-specific blood transfusion and kidney transplantation more than six years were enrolled, and ten healthy volunteers as healthy control (HC). Posttransplant patients were divided into two groups depending on their immunosuppressive therapy: calcineurin inhibitors (CNI) and rapamycin (Rapa). Analyzed the expression of CD4+CD25+Foxp3+T cells and Th17 T cells in the peripheral blood under the stimulate condition (phorbol myfismte acetate and ionomycin) and no-stimulate condition for all objects by flow cytometry, and the mixed lymphocyte reaction (MLR) in recipient with their donors and independent third party by methyl thiazolyl tetrazolium (MTT). Results: The proportion of CD4+CD25+Foxp3+ T cells in the peripheral blood under the stimulate condition and no-stimulate condition in group of Rapa were 2.24% and 2.14%, respectively, significant higher than group of CNI (P< 0.05, Table 1), and, there was no significant difference for the proportion of Th17 T cells between the group of Rapa and CNI. The ratio of CD4+CD25+Foxp3+/Th17 T cells in group of Rapa under the stimulate condition and no-stimulate condition were 3.42 and 8.92, respectively, significant higher than group of CNI (P< 0.05, Table 1). In all groups, the result of MLR with independent third party higher than their donors, and the MLR with independent third party in group of Rapa was higher than group of CNI.[Table 1 The expression of Treg and Th17 T cells]Conclusion: This study showed in living-related donor kidney recipients who received combined donor-specific blood transfusion and kidney transplantation obtain better long-term graft and patient survival. Increased numbers of CD4+CD25+Foxp3+ T cells and the ratio of CD4+CD25+Foxp3+/Th17 T cells and higher MLR with independent third party in group of Rapa compared with group of CNI. Therefore, monitoring of Treg in the peripheral blood as a biomarker of tolerance may detect unresponsiveness to the graft.

Induction Therapies Determine the Distribution of Perforin and Granzyme B Transcripts in Kidney Transplant Recipients

Analysis of Granzyme B Mrna and Perforin Mrna Levels in Urine for Renal Transplantation Patients with De-Layed Graft Function

Effect of Different Induction Therapies on the Clinical Outcomes of ABO-incompatible Living Donor Kidney Transplantation Recipients

Perforin expression in peripheral blood lymphocyte in renal transplantation

Interleukin-2 Receptor Antagonist Compared With Antithymocyte Globulin Induction Therapy In Kidney Transplantation From Donors After Cardiac Death

Perforin and Granzyme B Expression in Liver Allograft Rejection

Serial peripheral blood perforin and granzyme B gene expression measurements for prediction of acute rejection in kidney graft recipients

Long-term Effectiveness of Anti-Interleukin-2 Receptor Antibodies Vs.rabbit Antithymocyte Globulin As Induction Therapy in Kidney Transplantation

Plasma Donor-Derived Cell-Free DNA Levels Are Associated with the Inflammatory Burden and Macrophage Extracellular Trap Activity in Renal Allografts.

Elevated serum IL-21 levels are associated with stable immune status in kidney transplant recipients and a mouse model of kidney transplantation

High Serum Level of the Soluble CD30 Identifies Chinese Kidney Transplant Recipients at High Risk of Unfavorable Outcome

[Influence of Pre-Transplant Serum Level of Soluble CD30 on the Long-Term Survival Rates of Kidney Transplant Recipients and Grafts].

IMPACT OF PRE-TRANSPLANT SERUM LEVELS OF IP-10,MIG AND BLC ON ACUTE REJECTION EPISODE

The impact of induction therapy on the risk of posttransplant lymphoproliferative disorder in adult kidney transplant recipients with donor-recipient serological Epstein-Barr virus mismatch

[Sensitivity and specificity of granzyme B and perforin in diagnosing acute rejection after liver transplantation].

The Mixed Lymphocyte Reaction and the Ratio of Cd4(+)Cd25(+)Foxp3(+)/Th17 T Cell in Long Term Graft and Recipents Survival of Kidney Transplantation with Living-Related Donor

Effect of Different Induction Immunosuppression on the Incidence of Infectious Complications after Kidney Transplantation—Single Center Study

Induction Versus Maintenance Immunosuppression After Intestinal Transplant: Determining Which Treatment Most Impacts Long-Term Patient And Graft Survival

The Effect of Induction Therapy on Antibody-Mediated Rejection in Kidney Transplantation: A Network Meta-Analysis Using Recent Data

Outcomes of Induction Antibody Therapies in the Nonbroadly Sensitized Adult Deceased Donor Kidney Transplant Recipients: a Retrospective Cohort Registry Analysis

Alterations in circulating measures of Th2 immune responses pre-lung transplant associates with reduced primary graft dysfunction